| Number | GOID | Name | p-value | FDR(GOSSIP) | FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 6958 | complement activation, classical pathway | 0.001 | 0.21 | 0.11 | 0.27 | 0.24 | 0.08 | 0.51 | 0.27
|
| 2 | 3811 | complement activity | 0.001 | 0.21 | 0.15 | 0.409 | 0.33 | 0.08 | 0.51 | 0.41
|
| 3 | 45944 | positive regulation of transcription from Pol II promoter | 0.002 | 0.21 | 0.25 | 0.75 | 0.52 | 0.08 | 0.51 | 0.75
|
| 4 | 45893 | positive regulation of transcription, DNA-dependent | 0.002 | 0.21 | 0.25 | 0.75 | 0.52 | 0.08 | 0.51 | 0.75
|
| 5 | 6956 | complement activation | 0.003 | 0.21 | 0.302 | 0.95 | 0.61 | 0.08 | 0.51 | 0.96
|
| 6 | 74 | regulation of cell cycle | 0.004 | 0.21 | 0.31 | 1 | 0.67 | 0.08 | 0.51 | 1
|
| 7 | 16064 | humoral defense mechanism (sensu Vertebrata) | 0.004 | 0.21 | 0.34 | 1 | 0.69 | 0.08 | 0.51 | 1
|
| 8 | 6959 | humoral immune response | 0.004 | 0.21 | 0.34 | 1 | 0.69 | 0.08 | 0.51 | 1
|
| 9 | 45941 | positive regulation of transcription | 0.005 | 0.22 | 0.39 | 1 | 0.75 | 0.08 | 0.51 | 1
|
| 10 | 6366 | transcription from Pol II promoter | 0.008 | 0.25 | 0.47 | 1 | 0.87 | 0.08 | 0.51 | 1
|
| 11 | 19835 | cytolysis | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 12 | 30855 | epithelial cell differentiation | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 13 | 35026 | leading edge cell differentiation | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 14 | 4887 | thyroid hormone receptor activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 15 | 15051 | X-opioid receptor activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 16 | 4985 | opioid receptor activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 17 | 4218 | cathepsin S activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 18 | 3796 | lysozyme activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 19 | 5980 | glycogen catabolism | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 20 | 9251 | glucan catabolism | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 21 | 272 | polysaccharide catabolism | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 22 | 4112 | cyclic-nucleotide phosphodiesterase activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 23 | 4114 | 3',5'-cyclic-nucleotide phosphodiesterase activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 24 | 3795 | antimicrobial peptide activity | 0.01 | 0.38 | 0.96 | 1 | 0.93 | 0.08 | 0.51 | 1
|
| 25 | 6955 | immune response | 0.01 | 0.38 | 0.97 | 1 | 0.94 | 0.08 | 0.51 | 1
|
| 26 | 6351 | transcription, DNA-dependent | 0.01 | 0.38 | 0.97 | 1 | 0.95 | 0.08 | 0.51 | 1
|
| 27 | 4553 | hydrolase activity, hydrolyzing O-glycosyl compounds | 0.01 | 0.38 | 0.97 | 1 | 0.95 | 0.08 | 0.51 | 1
|
| 28 | 9056 | catabolism | 0.01 | 0.38 | 0.97 | 1 | 0.97 | 0.08 | 0.51 | 1
|
| 29 | 6350 | transcription | 0.01 | 0.38 | 0.97 | 1 | 0.98 | 0.08 | 0.51 | 1
|
| 30 | 8369 | obsolete molecular function | 0.01 | 0.38 | 0.97 | 1 | 0.98 | 0.08 | 0.51 | 1
|
| 31 | 16798 | hydrolase activity, acting on glycosyl bonds | 0.02 | 0.38 | 0.98 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 32 | 6952 | defense response | 0.02 | 0.38 | 0.98 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 33 | 46072 | dTDP metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 34 | 9196 | pyrimidine deoxyribonucleoside diphosphate metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 35 | 9186 | deoxyribonucleoside diphosphate metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 36 | 9262 | deoxyribonucleotide metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 37 | 4558 | alpha-glucosidase activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 38 | 1502 | cartilage condensation | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 39 | 1614 | purinergic nucleotide receptor activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 40 | 16502 | nucleotide receptor activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 41 | 45028 | purinergic nucleotide receptor activity, G-protein coupled | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 42 | 16998 | cell wall catabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 43 | 9263 | deoxyribonucleotide biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 44 | 9189 | deoxyribonucleoside diphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 45 | 9197 | pyrimidine deoxyribonucleoside diphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 46 | 6233 | dTDP biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 47 | 1608 | nucleotide receptor activity, G-protein coupled | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 48 | 9202 | deoxyribonucleoside triphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 49 | 9212 | pyrimidine deoxyribonucleoside triphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 50 | 6235 | dTTP biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 51 | 9221 | pyrimidine deoxyribonucleotide biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 52 | 9148 | pyrimidine nucleoside triphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 53 | 9133 | nucleoside diphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 54 | 9139 | pyrimidine nucleoside diphosphate biosynthesis | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 55 | 9200 | deoxyribonucleoside triphosphate metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 56 | 9211 | pyrimidine deoxyribonucleoside triphosphate metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 57 | 46075 | dTTP metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 58 | 9219 | pyrimidine deoxyribonucleotide metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 59 | 4798 | thymidylate kinase activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 60 | 9138 | pyrimidine nucleoside diphosphate metabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 61 | 4983 | neuropeptide Y receptor activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 62 | 320 | re-entry into mitotic cell cycle | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 63 | 45444 | adipocyte differentiation | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 64 | 42923 | neuropeptide binding | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 65 | 8188 | neuropeptide receptor activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.51 | 1
|
| 66 | 16052 | carbohydrate catabolism | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.08 | 0.53 | 1
|
| 67 | 4197 | cysteine-type endopeptidase activity | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.09 | 0.56 | 1
|
| 68 | 5516 | calmodulin binding | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.09 | 0.607 | 1
|
| 69 | 9613 | response to pest/pathogen/parasite | 0.02 | 0.38 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 70 | 8234 | cysteine-type peptidase activity | 0.03 | 0.38 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 71 | 8443 | phosphofructokinase activity | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 72 | 30693 | caspase activity | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 73 | 5945 | 6-phosphofructokinase complex | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 74 | 8631 | induction of apoptosis by oxidative stress | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 75 | 3872 | 6-phosphofructokinase activity | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 76 | 2009 | morphogenesis of an epithelium | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 77 | 15467 | G-protein activated inward rectifier potassium channel activity | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 78 | 9132 | nucleoside diphosphate metabolism | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.104 | 0.64 | 1
|
| 79 | 3700 | transcription factor activity | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.108 | 0.66 | 1
|
| 80 | 5975 | carbohydrate metabolism | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.72 | 1
|
| 81 | 5654 | nucleoplasm | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 82 | 9607 | response to biotic stimulus | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 83 | 6355 | regulation of transcription, DNA-dependent | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 84 | 5764 | lysosome | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 85 | 323 | lytic vacuole | 0.03 | 0.41 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 86 | 15926 | glucosidase activity | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 87 | 9147 | pyrimidine nucleoside triphosphate metabolism | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 88 | 5242 | inward rectifier potassium channel activity | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 89 | 8528 | peptide receptor activity, G-protein coupled | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 90 | 1653 | peptide receptor activity | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 91 | 8629 | induction of apoptosis by intracellular signals | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 92 | 45449 | regulation of transcription | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.11 | 0.73 | 1
|
| 93 | 3677 | DNA binding | 0.04 | 0.44 | 0.99 | 1 | 0.99 | 0.12 | 0.76 | 1
|
| 94 | 5773 | vacuole | 0.04 | 0.45 | 0.99 | 1 | 0.99 | 0.13 | 0.82 | 1
|
| 95 | 6357 | regulation of transcription from Pol II promoter | 0.04 | 0.45 | 0.99 | 1 | 0.99 | 0.13 | 0.82 | 1
|
| 96 | 5665 | DNA-directed RNA polymerase II, core complex | 0.05 | 0.48 | 0.99 | 1 | 0.99 | 0.13 | 0.84 | 1
|
| 97 | 1503 | ossification | 0.05 | 0.48 | 0.99 | 1 | 0.99 | 0.13 | 0.84 | 1
|
| 98 | 5261 | cation channel activity | 0.05 | 0.48 | 0.99 | 1 | 0.99 | 0.13 | 0.84 | 1
|
| 99 | 7049 | cell cycle | 0.05 | 0.48 | 0.99 | 1 | 0.99 | 0.14 | 0.88 | 1
|
| 100 | 16538 | cyclin-dependent protein kinase regulator activity | 0.06 | 0.51 | 0.99 | 1 | 1 | 0.15 | 0.96 | 1
|
| 101 | 16591 | DNA-directed RNA polymerase II, holoenzyme | 0.06 | 0.51 | 0.99 | 1 | 1 | 0.15 | 0.96 | 1
|
| 102 | 46849 | bone remodeling | 0.06 | 0.51 | 0.99 | 1 | 1 | 0.15 | 0.96 | 1
|
| 103 | 19200 | carbohydrate kinase activity | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 104 | 8016 | regulation of heart rate | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 105 | 6073 | glucan metabolism | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 106 | 5977 | glycogen metabolism | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 107 | 19201 | nucleotide kinase activity | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 108 | 6091 | energy pathways | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 109 | 15980 | energy derivation by oxidation of organic compounds | 0.07 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 110 | 30154 | cell differentiation | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 111 | 12502 | induction of programmed cell death | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 112 | 43068 | positive regulation of programmed cell death | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 113 | 30880 | RNA polymerase complex | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 114 | 43067 | regulation of programmed cell death | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 115 | 6220 | pyrimidine nucleotide metabolism | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 116 | 6917 | induction of apoptosis | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 117 | 43065 | positive regulation of apoptosis | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 118 | 8081 | phosphoric diester hydrolase activity | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 119 | 6221 | pyrimidine nucleotide biosynthesis | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 120 | 8015 | circulation | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 121 | 6112 | energy reserve metabolism | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 122 | 5976 | polysaccharide metabolism | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 123 | 30528 | transcription regulator activity | 0.08 | 0.51 | 1 | 1 | 1 | 0.17 | 1 | 1
|
| 124 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.08 | 0.51 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 125 | 9605 | response to external stimulus | 0.08 | 0.51 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 126 | 160 | two-component signal transduction system (phosphorelay) | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 127 | 16563 | transcriptional activator activity | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 128 | 16776 | phosphotransferase activity, phosphate group as acceptor | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 129 | 42277 | peptide binding | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 130 | 8283 | cell proliferation | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 131 | 30001 | metal ion transport | 0.09 | 0.52 | 1 | 1 | 1 | 0.18 | 1 | 1
|
| 132 | 4879 | ligand-dependent nuclear receptor activity | 0.101 | 0.55 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 133 | 5575 | cellular_component | 0.11 | 0.55 | 1 | 1 | 1 | 0.21 | 1 | 1
|
| 134 | 5262 | calcium channel activity | 0.11 | 0.58 | 1 | 1 | 1 | 0.21 | 1 | 1
|
| 135 | 1501 | skeletal development | 0.12 | 0.604 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 136 | 3899 | DNA-directed RNA polymerase activity | 0.12 | 0.604 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 137 | 19205 | nucleobase, nucleoside, nucleotide kinase activity | 0.12 | 0.61 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 138 | 46873 | metal ion transporter activity | 0.12 | 0.61 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 139 | 5216 | ion channel activity | 0.13 | 0.61 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 140 | 5874 | microtubule | 0.13 | 0.62 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 141 | 3928 | RAB small monomeric GTPase activity | 0.14 | 0.62 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 142 | 5249 | voltage-gated potassium channel activity | 0.14 | 0.62 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 143 | 1584 | rhodopsin-like receptor activity | 0.14 | 0.62 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 144 | 15268 | alpha-type channel activity | 0.15 | 0.62 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 145 | 15267 | channel/pore class transporter activity | 0.15 | 0.62 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 146 | 19207 | kinase regulator activity | 0.15 | 0.63 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 147 | 19887 | protein kinase regulator activity | 0.15 | 0.63 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 148 | 16329 | apoptosis regulator activity | 0.15 | 0.63 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 149 | 9653 | morphogenesis | 0.17 | 0.66 | 1 | 1 | 1 | 0.302 | 1 | 1
|
| 150 | 6096 | glycolysis | 0.17 | 0.67 | 1 | 1 | 1 | 0.302 | 1 | 1
|
| 151 | 16787 | hydrolase activity | 0.17 | 0.67 | 1 | 1 | 1 | 0.307 | 1 | 1
|
| 152 | 42981 | regulation of apoptosis | 0.18 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 153 | 8219 | cell death | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 154 | 4930 | G-protein coupled receptor activity | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 155 | 6007 | glucose catabolism | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 156 | 19320 | hexose catabolism | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 157 | 46365 | monosaccharide catabolism | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 158 | 46164 | alcohol catabolism | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 159 | 4872 | receptor activity | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 160 | 6812 | cation transport | 0.19 | 0.68 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 161 | 9142 | nucleoside triphosphate biosynthesis | 0.201 | 0.68 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 162 | 5267 | potassium channel activity | 0.201 | 0.68 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 163 | 16265 | death | 0.203 | 0.68 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 164 | 9141 | nucleoside triphosphate metabolism | 0.21 | 0.69 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 165 | 6006 | glucose metabolism | 0.21 | 0.704 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 166 | 8150 | biological_process | 0.22 | 0.704 | 1 | 1 | 1 | 0.35 | 1 | 1
|
| 167 | 910 | cytokinesis | 0.22 | 0.71 | 1 | 1 | 1 | 0.35 | 1 | 1
|
| 168 | 5634 | nucleus | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 169 | 7275 | development | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 170 | 7582 | physiological process | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 171 | 5244 | voltage-gated ion channel activity | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 172 | 5200 | structural constituent of cytoskeleton | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 173 | 6813 | potassium ion transport | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 174 | 6950 | response to stress | 0.24 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 175 | 8233 | peptidase activity | 0.25 | 0.71 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 176 | 16779 | nucleotidyltransferase activity | 0.25 | 0.72 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 177 | 5996 | monosaccharide metabolism | 0.25 | 0.72 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 178 | 19318 | hexose metabolism | 0.25 | 0.72 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 179 | 6508 | proteolysis and peptidolysis | 0.26 | 0.73 | 1 | 1 | 1 | 0.38 | 1 | 1
|
| 180 | 5829 | cytosol | 0.27 | 0.75 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 181 | 30163 | protein catabolism | 0.28 | 0.75 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 182 | 7017 | microtubule-based process | 0.29 | 0.75 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 183 | 9057 | macromolecule catabolism | 0.29 | 0.75 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 184 | 9165 | nucleotide biosynthesis | 0.306 | 0.77 | 1 | 1 | 1 | 0.42 | 1 | 1
|
| 185 | 6092 | main pathways of carbohydrate metabolism | 0.306 | 0.77 | 1 | 1 | 1 | 0.42 | 1 | 1
|
| 186 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.31 | 0.77 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 187 | 287 | magnesium ion binding | 0.31 | 0.77 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 188 | 5623 | cell | 0.32 | 0.77 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 189 | 6811 | ion transport | 0.32 | 0.77 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 190 | 3779 | actin binding | 0.32 | 0.77 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 191 | 5615 | extracellular space | 0.34 | 0.78 | 1 | 1 | 1 | 0.47 | 1 | 1
|
| 192 | 9117 | nucleotide metabolism | 0.34 | 0.79 | 1 | 1 | 1 | 0.47 | 1 | 1
|
| 193 | 3676 | nucleic acid binding | 0.36 | 0.79 | 1 | 1 | 1 | 0.48 | 1 | 1
|
| 194 | 9887 | organogenesis | 0.36 | 0.79 | 1 | 1 | 1 | 0.48 | 1 | 1
|
| 195 | 6066 | alcohol metabolism | 0.37 | 0.804 | 1 | 1 | 1 | 0.501 | 1 | 1
|
| 196 | 3925 | small monomeric GTPase activity | 0.38 | 0.807 | 1 | 1 | 1 | 0.507 | 1 | 1
|
| 197 | 5667 | transcription factor complex | 0.39 | 0.807 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 198 | 9987 | cellular process | 0.39 | 0.807 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 199 | 5576 | extracellular | 0.39 | 0.807 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 200 | 5622 | intracellular | 0.41 | 0.81 | 1 | 1 | 1 | 0.54 | 1 | 1
|
| 201 | 42578 | phosphoric ester hydrolase activity | 0.42 | 0.81 | 1 | 1 | 1 | 0.54 | 1 | 1
|
| 202 | 4871 | signal transducer activity | 0.42 | 0.81 | 1 | 1 | 1 | 0.54 | 1 | 1
|
| 203 | 7399 | neurogenesis | 0.42 | 0.81 | 1 | 1 | 1 | 0.54 | 1 | 1
|
| 204 | 8092 | cytoskeletal protein binding | 0.43 | 0.81 | 1 | 1 | 1 | 0.55 | 1 | 1
|
| 205 | 8152 | metabolism | 0.44 | 0.82 | 1 | 1 | 1 | 0.55 | 1 | 1
|
| 206 | 15672 | monovalent inorganic cation transport | 0.45 | 0.82 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 207 | 7186 | G-protein coupled receptor protein signaling pathway | 0.46 | 0.83 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 208 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.46 | 0.83 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 209 | 3674 | molecular_function | 0.47 | 0.83 | 1 | 1 | 1 | 0.58 | 1 | 1
|
| 210 | 7010 | cytoskeleton organization and biogenesis | 0.49 | 0.83 | 1 | 1 | 1 | 0.609 | 1 | 1
|
| 211 | 7264 | small GTPase mediated signal transduction | 0.49 | 0.83 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 212 | 4888 | transmembrane receptor activity | 0.504 | 0.83 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 213 | 5515 | protein binding | 0.506 | 0.83 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 214 | 8151 | cell growth and/or maintenance | 0.509 | 0.83 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 215 | 3924 | GTPase activity | 0.52 | 0.84 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 216 | 15075 | ion transporter activity | 0.52 | 0.84 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 217 | 5215 | transporter activity | 0.53 | 0.84 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 218 | 16301 | kinase activity | 0.53 | 0.84 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 219 | 6915 | apoptosis | 0.54 | 0.85 | 1 | 1 | 1 | 0.64 | 1 | 1
|
| 220 | 12501 | programmed cell death | 0.55 | 0.85 | 1 | 1 | 1 | 0.64 | 1 | 1
|
| 221 | 6996 | organelle organization and biogenesis | 0.58 | 0.87 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 222 | 16788 | hydrolase activity, acting on ester bonds | 0.58 | 0.87 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 223 | 5887 | integral to plasma membrane | 0.59 | 0.87 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 224 | 7165 | signal transduction | 0.60 | 0.87 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 225 | 16740 | transferase activity | 0.61 | 0.87 | 1 | 1 | 1 | 0.70 | 1 | 1
|
| 226 | 30234 | enzyme regulator activity | 0.62 | 0.87 | 1 | 1 | 1 | 0.71 | 1 | 1
|
| 227 | 5525 | GTP binding | 0.64 | 0.87 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 228 | 19001 | guanyl nucleotide binding | 0.64 | 0.87 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 229 | 8565 | protein transporter activity | 0.64 | 0.87 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 230 | 3824 | catalytic activity | 0.67 | 0.89 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 231 | 15630 | microtubule cytoskeleton | 0.68 | 0.89 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 232 | 5783 | endoplasmic reticulum | 0.70 | 0.89 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 233 | 7166 | cell surface receptor linked signal transduction | 0.70 | 0.89 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 234 | 7028 | cytoplasm organization and biogenesis | 0.72 | 0.90 | 1 | 1 | 1 | 0.79 | 1 | 1
|
| 235 | 5488 | binding | 0.73 | 0.90 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 236 | 7154 | cell communication | 0.76 | 0.90 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 237 | 6886 | intracellular protein transport | 0.76 | 0.90 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 238 | 15031 | protein transport | 0.78 | 0.90 | 1 | 1 | 1 | 0.84 | 1 | 1
|
| 239 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.78 | 0.90 | 1 | 1 | 1 | 0.84 | 1 | 1
|
| 240 | 16020 | membrane | 0.78 | 0.90 | 1 | 1 | 1 | 0.84 | 1 | 1
|
| 241 | 16817 | hydrolase activity, acting on acid anhydrides | 0.79 | 0.90 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 242 | 5198 | structural molecule activity | 0.79 | 0.90 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 243 | 7242 | intracellular signaling cascade | 0.79 | 0.90 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 244 | 6810 | transport | 0.81 | 0.90 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 245 | 5737 | cytoplasm | 0.81 | 0.90 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 246 | 46907 | intracellular transport | 0.83 | 0.90 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 247 | 5856 | cytoskeleton | 0.84 | 0.90 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 248 | 16043 | cell organization and biogenesis | 0.85 | 0.90 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 249 | 16021 | integral to membrane | 0.85 | 0.90 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 250 | 46872 | metal ion binding | 0.86 | 0.90 | 1 | 1 | 1 | 0.89 | 1 | 1
|
| 251 | 9059 | macromolecule biosynthesis | 0.89 | 0.90 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 252 | 5886 | plasma membrane | 0.90 | 0.90 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 253 | 5524 | ATP binding | 0.90 | 0.90 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 254 | 30554 | adenyl nucleotide binding | 0.91 | 0.90 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 255 | 9058 | biosynthesis | 0.93 | 0.90 | 1 | 1 | 1 | 0.94 | 1 | 1
|
| 256 | 17076 | purine nucleotide binding | 0.93 | 0.90 | 1 | 1 | 1 | 0.94 | 1 | 1
|
| 257 | 166 | nucleotide binding | 0.93 | 0.90 | 1 | 1 | 1 | 0.94 | 1 | 1
|
| 258 | 19538 | protein metabolism | 0.97 | 0.90 | 1 | 1 | 1 | 0.97 | 1 | 1
|
| 259 | 3673 | Gene_Ontology | 1 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|